JPM26: Medtech VC sees kidney care entering new era of innovation
GlobalData analysis forecasts that the global nephrology and urology devices market will reach a valuation of $12.43bn in 2034, up...
Year: 2026
Post-Surgery Strategy Shows Promise in Delaying Liver Cancer Recurrence
Newswise — Hepatocellular carcinoma is one of the leading causes of cancer-related death worldwide, largely due to its high rate...
Web-based tool could aid in early detection and prevention of chronic kidney disease
Subtle abnormalities in kidney function – even within the range considered normal – may help identify people at risk of...
New device for blood clot treatment helps patients avoid surgery
By Olivia Lavery A Unity Health Toronto team led by Dr. Andrew Brown has become one of the first...
Von Willebrand Disease – UF Health
Alternative NamesBleeding disorder - von Willebrand CausesVon Willebrand disease is caused by a deficiency or poor functioning of von Willebrand...
Australia Advanced Liver Cancer Market: Clinical Innovation, Targeted Therapies & the Future of Oncology Care
Australia advanced liver cancer market is witnessing a decisive transformation as medical science, targeted therapies and healthcare accessibility converge to...
